TD Cowen cuts Ionis Pharmaceuticals stock price target on Tryngolza miss
AI Summary
TD Cowen lowered its price target for Ionis Pharmaceuticals after Tryngolza missed expectations. The article description does not provide details about the size of the miss or the revised target.